Ellen Rooijen
Sr. Director, Head of R&D Operations and Strategy, Head of Delivery Technologies at Montai Health - Cambridge, Massachusetts, United States
Ellen Rooijen's Colleagues at Montai Health
Ellen Rooijen's Contact Details
Boston,Massachusetts,United States
Montai Health
Ellen Rooijen's Company Details
Montai Health is unlocking the power of nature with its pioneering AI-powered CONECTA™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. Anthromolecule chemistry has co-evolved with humans through long term chronic consumption in foods, herbs, and traditional medicines. It offers a privileged starting point for developing breakthrough small-molecule medicines to address chronic diseases. Montai's CONECTA platform is powered by hyper-efficient, generalizable ML and the aggregation of Anthromolecule chemistry at industry first scale to predictably discover precision-matched, human-qualified chemistry that potently and safely engages validated biological pathways. Montai is rapidly advancing a pipeline of first-in-class or best-in-class small-molecule assets against multiple powerful, validated biological pathways in inflammation and autoimmune. Montai was founded in Flagship Labs in 2019. For more information, please visit www.montai.com.